InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2018-11-20 | Greg Gianforte | house | Sale | $50,001 - $100,000 |
| 2018-07-05 | Greg Gianforte | house | Sale | $15,001 - $50,000 |
No financial data available for FMS.
Company may not file with SEC or CIK is unresolved.
BrightSpring Before Q1 Earnings: Buy, Sell or Hold the Stock Now?
Baxter Q1 Preview: Will Operational Headwinds Weigh on Results Again?
Humacyte regains ex-U.S. rights to Symvess from Fresenius Medical Care
Humacyte Expands Commercial and Business Development Opportunities Through Realignment of Ex-U.S. Rights to Symvess®
Quest Diagnostics Q1 Earnings Call Highlights
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
Focus Graphite Initiates Joint Development with Forge Nano to Evaluate Advanced Coating Technology for Lac Knife Graphite
Is Fresenius Medical Care (XTRA:FME) Now Attractively Priced After Years Of Share Price Weakness?
Fundamental Research Corp. Initiates Coverage on Focus Graphite Inc.
Northrop Grumman wins $127M U.S. Navy deal for 28 Coyote targets
DaVita tops chart as the only large-cap healthcare services name rated Strong Buy
Fresenius Medical Care AG (FMS) Q4 2025 Earnings Call Transcript